Telocytes involvement in recovery after myocardial infarction

doi:10.3969/j.issn.1007-2861.2017.02.004

上海大学学报(自然科学版) ›› 2017, Vol. 23 ›› Issue (2): 155-160.doi: 10.3969/j.issn.1007-2861.2017.02.004

• 精准与转化医学 • 下一篇

Telocytes involvement in recovery after myocardial infarction

BANCIU Daniel Dumitru^1,2, CRETOIU Dragos^3,4, CRETOIU Sanda^3,4, BANCIU Adela^1,2,5

1. Research Beyond Limits SRL, Bucharest 040234, Romania;
2. University of Bucharest, Bucharest 050107, Romania;
3. Carol Davila University of Medicine and Pharmacy, Bucharest 020021, Romania;
4. National Institute of Research-Development in the Pathology Domain and Biomedical Sciences Victor Babes, Bucharest 050096, Romania;
5. Constantin Brˆancusi University, Gorj 210135, Romania

收稿日期:2017-04-05 出版日期:2017-04-30 发布日期:2017-04-30
通讯作者: Banciu Adela, E-mail: adela.banciu79@gmail.com, adela@researchbeyondlimits.ro
作者简介:Banciu Adela, E-mail: adela.banciu79@gmail.com, adela@researchbeyondlimits.ro

Telocytes involvement in recovery after myocardial infarction

Received:2017-04-05 Online:2017-04-30 Published:2017-04-30
Supported by:
Romanian National Authority for Scientific Research, CNCS—UEFISCDI, PNII (82/2012, 194/2014)

摘要/Abstract

摘要：

Myocardial infarction (MI) is a disorder that lowers the lifespan and quality of life. Reperfusion treatment as early as possible is the most effective solution, with an increased focus on post-MI medication. In the recovery process after MI, telocytes (TCs) appear to play an important role, which develops a large number of questions awaiting answers. Defining possible signaling mechanisms involved in recovery after MI may lead to identification the limits of current therapies, and development of new therapeutic solutions.

telocytes

Abstract:

Key words: myocardial infarction , stem cell

telocytes

BANCIU Daniel Dumitru1,2, CRETOIU Dragos3,4, CRETOIU Sanda3,4, BANCIU Adela1,2,5. Telocytes involvement in recovery after myocardial infarction[J]. 上海大学学报(自然科学版), 2017, 23(2): 155-160.

参考文献

[1] Popescu L M, Faussone-Pellegrini M S. TELOCYTES—a case of serendipity: the winding way from interstitial cells of Cajal (ICC), via interstitial Cajal-like cells (ICLC) to TELOCYTES [J]. Journal of Cellular Molecular Medicine, 2010, 14(4): 729-740.
[2] Faussone-Pellegrini M S, Popescu L M. Telocytes [J]. Biomolecular Concepts, 2011, 2(6): 2481-2489.
[3] Cretoiu S M, Popescu L M. Telocytes revisited [J]. Biomolecular Concepts, 2014, 5(5): 353-369.
[4] Cretoiu S M, Cretoiu D, Popescu L M. Human myometrium-the ultrastructural 3D network of telocytes [J]. Journal of Cellular Molecular Medicine, 2012, 16(11): 2844-2849.
[5] Xiao J,Wang F, Liu Z, Yang C. Telocytes in liver: electron microscopic and immunofluorescent evidence [J]. Journal of Cellular Molecular Medicine, 2013, 17(12): 1537-1542.
[6] Cretoiu D, Cretoiu S M, Simionescu A A, et al. Telocytes, a distinct type of cell among the stromal cells present in the lamina propria of jejunum [J]. Histology and Histopathology, 2012, 27(8): 1067-1078.
[7] Zheng Y, Li H, Manole C G, et al. Telocytes in trachea and lungs [J]. Journal of Cellular and Molecular Medicine, 2011, 15(10): 2262-2268.
[8] Popescu B O, Gherghiceanu M, Kostin S, et al. Telocytes in meninges and choroid plexus [J]. Neuroscience Letters, 2012, 516(2): 265-269.
[9] Vannucchi M G, Traini C, Manetti M, et al. Telocytes express PDGFRa in the human gastrointestinal tract [J]. Journal of Cellular and Molecular Medicine, 2013, 17(9): 1099-1108.
[10] Mou Y, Wang Y, Li J, et al. Immunohistochemical characterization and functional identification of mammary gland telocytes in the self-assembly of reconstituted breast cancer tissue in vitro [J]. Journal of Cellular and Molecular Medicine, 2013, 17(1): 65-75.
[11] Kostin S. Myocardial telocytes: a specific new cellular entity [J]. Journal of Cellular and Molecular Medicine, 2010, 14(7): 1917-1921.
[12] Cantarero I, Luesma M J, Junquera C. The primary cilium of telocytes in the vasculature: electron microscope imaging [J]. Journal of Cellular and Molecular Medicine, 2011, 15(12): 2594-2600.
[13] Gherghiceanu M, Popescu L M. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images [J]. Journal of Cellular and Molecular Medicine, 2010, 14(4): 871-877.

[14] Popescu L M, Manole E, Serboiu C S, et al. Identification of telocytes in skeletal muscle interstitium: implication for muscle regeneration [J]. Journal of Cellular and Molecular Medicine, 2011, 15(6): 1379-1392.
[15] Chen X, Zheng Y, Manole C G, et al. Telocytes in human oesophagus [J]. Journal of Cellular and Molecular Medicine, 2013, 17(11): 1506-1512.
[16] Cretoiu D, Hummel E, Zimmerann H, et al. Human cardiac telocytes: 3D imaging by FIBSEM tomography [J]. Journal of Cellular and Molecular Medicine, 2014, 18(11): 2157-2164.
[17] Popescu L M, Fertig E T, Gherghiceanu M. Reaching out: junctions between cardiac telocytes and cardiac stem cells in culture [J]. Journal of Cellular Molecular Medicine, 2016, 20(2): 370-380.
[18] Liao Z F, Cai D Q. Cardiac telocytes in regeneration of myocardium after myocardial infarction [J]. Advances in Experimental Medicine and Biology, 2016, 913: 229-239.
[19] Manole C G, Cismagiu V, Gherghiceanu M, et al. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis [J]. Journal of Cellular Molecular Medicine, 2011, 15(11): 2284-2296.
[20] Zhao B, Chen S, Liu J, et al. Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat [J]. Journal of Cellular and Molecular Medicine, 2013, 17(1): 123-133.
[21] Zhao B, Liao Z, Chen S, et al. Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats [J]. Journal of Cellular Molecular Medicine, 2014, 18(5): 780-789.
[22] Hong S J, Choi S C, Kim J S, et al. Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell
mobilisation [J]. Heart, 2010, 96(10): 756-764.
[23] Campeanu R A, Radu B M, Cretoiu S M, et al. Near-infrared low-level laser stimulation of telocytes from human myometrium [J]. Lasers in Medical Science, 2014, 29(6): 1867-1874.
[24] White H D, Norris R M, Brown M A, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction [J]. Circulation, 1987, 76(1): 44-51.
[25] Joyce E, Hoogslag G E, Leong D P, et al. Association between left ventricular global longitudinal strain and adverse left ventricular dilatation after ST-segment-elevation myocardial
infarction [J]. Circulation Cardiovascular Imaging, 2014, 7(1): 74-81.
[26] Cretoiu D, Radu B M, Banciu A, et al. Telocytes heterogeneity: from cellular morphology to functional evidence [J]. Seminars in Cell & Developmental Biology, 2017(64): 26-39.
[27] Schachinger V, Assmus B, Britten M B, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCAREAMI Trial [J]. Journal of American College of Cardiology, 2004, 44(8): 1690-1699.
[28] Fu S Y, Zhu H, Li S Y, et al.Telocytes in cardiac protection [J]. Current Stem Cell Research & Therapy, 2016, 11(5): 390-394.
[29] Xiao J, Chen P, Qu Y, et al. Telocytes in exercise-induced cardiac growth [J]. Journal of Cellular Moecular Medicine, 2016, 20(5): 973-979.

[30] Schulze H, Schepers U, Sandhoff K. Overexpression and mass spectrometry analysis of mature human acid ceramidase [J]. Biological Chemistry, 2007, 388(12): 1333-1343.
[31] Jia Y, Xu J, Yu Y, et al. Nifedipine inhibits angiotensinⅡ-induced cardiac fibrosis via downregulating Nox4-derived ROS generation and suppressing ERK1/2, JNK signaling pathways [J]. Pharmazie, 2013, 68(6): 435-441.
[32] Teng G Q, Svystonyuk D, Mewhort H E M, et al. Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis [J]. American Journal of Physiology: Heart
and Circulatory Physiology, 2015, 308(12): 1564-1574.
[33] Noppe G, Dufeys C, Buchlin P, et al. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKa1 [J].
Journal of Molecular and Cellular Cardiology, 2014, 74: 32-43.
[34] Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples)Ⅱtrial: impact of a single high loading dose of atorvastatin on periprocedural
myocardial infarction [J]. Journal of the American College of Cardiology, 2009, 54(23): 2157-2163.
[35] Teshima Y, Yufu K, Akioka H, et al. Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction [J]. Journal of Cardiology, 2009, 53(1): 58-64.
[36] Pedersen T R, Faergeman O, Kastelein J J P, et al. High-dose atorvastatin vs usualdose simvastatin for secondary prevention after myocardial infarction—the IDEAL study: a
randomized controlled trial [J]. JAMA, 2005, 294(19): 2437-2445.

Telocytes involvement in recovery after myocardial infarction

Telocytes involvement in recovery after myocardial infarction

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价